Welcome to National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad
NIPER HYDERABAD
National Institute of Pharmaceutical Education and Research
नाईपर हैदराबाद
राष्ट्रीय औषधीय शिक्षा एवं अनुसंधान संस्थान
Home / Important Links

Steering Committee Meetings
Committees
Tenders
Annual Procurement Plan
Downloads
Right to Information
Result Frame Work

Careers and Jobs at NIPER Hyderabad



The city offered multiple opportunities for you. Hyderabad is a place where lot of talent is available for pharma industry. We would say it is one of the top pharma hubs in the country after Mumbai and Ahmedabad. It’s a good place to be.

Job Title - No. of Positions Department/Division Closing date Job type
Download Notification | Application Form
  • Assistant Professors - 02
  • Associate Professor - 01
  • Finance Officer - 01
  • Secretary to Director - 01
  • Pharmacology & Toxicology / Regulatory Toxicology
  • Pharmaceutical Management
  • Administrative Positions
Soft copy - 31/07/2018
Hard copy - 06/08/2018
Teaching & Non-Teaching


Advantages of the Hyderabad / Deccan region : Hyderabad – The Pharma Hub of India

  • Hyderabad has a dominant position in Pharma Sector, it ranks first in manufacturing of bulk drugs and third in formulations in the country. It accounts for 40 per cent of the total Indian bulk drug production and 50 per cent of the bulk drug exports and is considered as the ‘Bulk Drug Capital of India’. In value terms, the industry is worth US$ 1.6 billion and exports accounting to over US$ 500 million. The Pharma industry and exports from here are expected to grow at 20 per cent annually.
  • The Telangana and Andhra Pradesh has over 2500 Pharma companies and is home to few of the top pharma companies Viz. Dr. Reddy’s Laboratories, Aurobindo pharmaceuticals, Mylan, Novartis, Nicholas Piramal, Divi Labs, NATCO Pharma, Gland Pharmaceuticals, etc.
  • There are more than 200 ‘Active Pharmaceutical Ingredients (API)’ units in the state, which are poised to grow at a rate of 10 to 15 per cent annually in the coming days.
  • Hyderabad is also referred to as the 'Vaccine Hub of India'. The city is home to leading vaccine producers such as Bharat Biotech, Biological E, Shantha Biotech, Indian Immunologicals, Globion Bio among others.
  • The Clinical Trial sector in Hyderabad has also witnessed a steep rise, with leading clinical trial companies such as GVK Biosciences, Sipra, Vimta Labs and Quintiles among others.
  • Hyderabad, joint capital of Telangana & Andhra Pradesh, is the sixth largest urban agglomeration of India. The City enjoys the advantage of its location and connects to all major cities in India through rail, road and air. The Hyderabad International Airport (Rajiv Gandhi International Airport) provides connectivity to major international destinations.
  • Hyderabad is ranked 3rd amongst top 20 cities in the world to become ‘Global Mega Hub’ by 2020. (Source: Doing Business 2011-report published by the World Bank Group). This is the only Indian city which figures in the top 10 large cities in the world considered as the ‘Most Sustainable Cities by 2020’
  • (Source: The Ethisphere Institute, USA). The economic growth drivers of the city are knowledge based industries such as Biotechnology, Pharmaceuticals and IT, ITES. The city houses several multinational life sciences giants like United States Pharmacopeia (USP), DuPont, Albany Molecular Research Inc. (AMRI), Nektar Therapeutics, Sanofi Aventis, Aptuit-Laurus etc. as well as home grown companies such as Dr Reddy’s, Aurobindo Pharma, Bharat Biotech etc
  • Several world renowned academic and research institutes and universities are based in Hyderabad, thus creating a vast pool of talent. It has a large number of super speciality hospitals well equipped for clinical trials of international standards, making it the ‘Health Capital of India’.

Welcome to National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad
Copyright © 2018 NIPER Hyderabad - Designed & Maintained by Computer Centre